ConductScience.org, home

Paper29618643

Comparison of Uncleaved and Mature Human Immunodeficiency Virus Membrane Envelope Glycoprotein Trimers.

Castillo-Menendez LR and 7 others. J Virol, 2018. Cited by 34 papers, by iCite.

Cite this record

ConductScience Library. Comparison of Uncleaved and Mature Human Immunodeficiency Virus Membrane Envelope Glycoprotein Trimers. Papers, record 29618643. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/29618643

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Comparison of Uncleaved and Mature Human Immunodeficiency Virus Membrane Envelope Glycoprotein Trimers.
PubMed
Journal
J Virol
PubMed
Year
2018
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S.
PubMed
Citations, by iCite
34
iCite
Relative citation ratio, by iCite
1.16
iCite
Revised in PubMed
2018-11-29
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Castillo-Menendez LRLuis R
2Witt KKristen
3Espy NNicole
4Princiotto AAmy
5Madani NNavid
6Pacheco BBeatriz
7Finzi AAndrés
8Sodroski JJoseph

Source PubMed

Download CSV of authors

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antibodies, NeutralizingMajor topic
Antibodies, ViralMajor topic
HIV AntibodiesMajor topic
HIV-1Major topic
env Gene Products, Human Immunodeficiency VirusMajor topic
Animals
Cell Line, Tumor
Dogs
Glutaral
HEK293 Cells
HIV Envelope Protein gp120
HIV Envelope Protein gp41
Humans
Protein Conformation
Protein Multimerization

Source PubMed

Download CSV of topics

Grants4

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
P01 GM056550NIGMS NIH HHSUnited StatesP01GM056550PubMed and NIHNIH RePORTER
R01 AI093256NIAID NIH HHSUnited StatesR01AI093256PubMed and NIHNIH RePORTER
R01 AI124982NIAID NIH HHSUnited StatesR01AI124982PubMed and NIHNIH RePORTER
UM1 AI100645NIAID NIH HHSUnited StatesUM1AI100645PubMed and NIHNIH RePORTER

Download CSV of grants

References126

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
111333908Identification of two sequences in the cytoplasmic tail of the human immunodeficiency virus type 1 envelope glycoprotein that inhibit cell surface expression.J Virol2001https://conductscience.org/library/papers/11333908PubMed
223426631Asymmetric recognition of the HIV-1 trimer by broadly neutralizing antibody PG9.Proc Natl Acad Sci U S A2013https://conductscience.org/library/papers/23426631PubMed
32849111Biosynthesis, cleavage, and degradation of the human immunodeficiency virus 1 envelope glycoprotein gp160.Proc Natl Acad Sci U S A1988https://conductscience.org/library/papers/2849111PubMed
424145402Cleavage strongly influences whether soluble HIV-1 envelope glycoprotein trimers adopt a native-like conformation.Proc Natl Acad Sci U S A2013https://conductscience.org/library/papers/24145402PubMed
523540694Somatic mutations of the immunoglobulin framework are generally required for broad and potent HIV-1 neutralization.Cell2013https://conductscience.org/library/papers/23540694PubMed
624068931A next-generation cleaved, soluble HIV-1 Env trimer, BG505 SOSIP.664 gp140, expresses multiple epitopes for broadly neutralizing but not non-neutralizing antibodies.PLoS Pathog2013https://conductscience.org/library/papers/24068931PubMed
719763271Limited neutralizing antibody specificities drive neutralization escape in early HIV-1 subtype C infection.PLoS Pathog2009https://conductscience.org/library/papers/19763271PubMed
812487827Characterization of CD4-induced epitopes on the HIV type 1 gp120 envelope glycoprotein recognized by neutralizing human monoclonal antibodies.AIDS Res Hum Retroviruses2002https://conductscience.org/library/papers/12487827PubMed
98755538Isolation of the human PC6 gene encoding the putative host protease for HIV-1 gp160 processing in CD4+ T lymphocytes.Proc Natl Acad Sci U S A1996https://conductscience.org/library/papers/8755538PubMed
109632396A conserved HIV gp120 glycoprotein structure involved in chemokine receptor binding.Science1998https://conductscience.org/library/papers/9632396PubMed
1112689414Effects of HIV type 1 envelope glycoprotein proteolytic processing on antigenicity.AIDS Res Hum Retroviruses2003https://conductscience.org/library/papers/12689414PubMed
1219965434Structural basis of immune evasion at the site of CD4 attachment on HIV-1 gp120.Science2009https://conductscience.org/library/papers/19965434PubMed
1310623724
A recombinant human immunodeficiency virus type 1 envelope glycoprotein complex stabilized by an intermolecular disulfide bond between the gp120 and gp41 subunits is an antigenic mimic of the trimeric virion-associated structure.
J Virol2000https://conductscience.org/library/papers/10623724PubMed
1416956933Antibody binding is a dominant determinant of the efficiency of human immunodeficiency virus type 1 neutralization.J Virol2006https://conductscience.org/library/papers/16956933PubMed
1521158699HIV type 1 Env precursor cleavage state affects recognition by both neutralizing and nonneutralizing gp41 antibodies.AIDS Res Hum Retroviruses2011https://conductscience.org/library/papers/21158699PubMed
1611222697Antibody binding and neutralization of primary and T-cell line-adapted isolates of human immunodeficiency virus type 1.J Virol2001https://conductscience.org/library/papers/11222697PubMed
1720981028Protein-binding assays in biological liquids using microscale thermophoresis.Nat Commun2010https://conductscience.org/library/papers/20981028PubMed
1815932765The impact of envelope glycoprotein cleavage on the antigenicity, infectivity, and neutralization sensitivity of Env-pseudotyped human immunodeficiency virus type 1 particles.Virology2005https://conductscience.org/library/papers/15932765PubMed
1924204277Viral escape from HIV-1 neutralizing antibodies drives increased plasma neutralization breadth through sequential recognition of multiple epitopes and immunotypes.PLoS Pathog2013https://conductscience.org/library/papers/24204277PubMed
208649512HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5.Nature1996https://conductscience.org/library/papers/8649512PubMed

See all 126 referencesDownload CSV of references

Cited by32

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 34 citations.

PMIDTitleJournalYearIn PapersSource
42207948Endocytic motif on HIV-1 Env regulates cleavage status and antibody neutralization of cell-free and cell-to-cell infection.J Virol2026https://conductscience.org/library/papers/42207948PubMed
41295975Characterization of full-length and cytoplasmic tail-truncated envelope glycoproteins incorporated into human immunodeficiency virus (HIV-1) virions and virus-like particles.J Virol2025https://conductscience.org/library/papers/41295975PubMed
39508605Inducible cell lines producing replication-defective human immunodeficiency virus particles containing envelope glycoproteins stabilized in a pretriggered conformation.J Virol2024https://conductscience.org/library/papers/39508605PubMed
38289101Inhibition of human immunodeficiency virus (HIV-1) infectivity by expression of poorly or broadly neutralizing antibodies against Env in virus-producing cells.J Virol2024https://conductscience.org/library/papers/38289101PubMed
37696048Alterations in gp120 glycans or the gp41 fusion peptide-proximal region modulate the stability of the human immunodeficiency virus (HIV-1) envelope glycoprotein pretriggered conformation.J Virol2023https://conductscience.org/library/papers/37696048PubMed
37549185Impact of stabilizing mutations on the antigenic profile and glycosylation of membrane-expressed HIV-1 envelope glycoprotein.PLoS Pathog2023https://conductscience.org/library/papers/37549185PubMed
37243275Temsavir Modulates HIV-1 Envelope Conformation by Decreasing Its Proteolytic Cleavage.Viruses2023https://conductscience.org/library/papers/37243275PubMed
36815832Characterization of the Human Immunodeficiency Virus (HIV-1) Envelope Glycoprotein Conformational States on Infectious Virus Particles.J Virol2023https://conductscience.org/library/papers/36815832PubMed
35694284HIV Transmembrane Glycoprotein Conserved Domains and Genetic Markers Across HIV-1 and HIV-2 Variants.Front Microbiol2022https://conductscience.org/library/papers/35694284PubMed
35343783Functional and Highly Cross-Linkable HIV-1 Envelope Glycoproteins Enriched in a Pretriggered Conformation.J Virol2022https://conductscience.org/library/papers/35343783PubMed
35323042The HIV Env Glycoprotein Conformational States on Cells and Viruses.mBio2022https://conductscience.org/library/papers/35323042PubMed
34835042HIV-1 Envelope Glycoproteins Proteolytic Cleavage Protects Infected Cells from ADCC Mediated by Plasma from Infected Individuals.Viruses2021https://conductscience.org/library/papers/34835042PubMed
34696383HIV-1 Envelope Glycoprotein Cell Surface Localization Is Associated with Antibody-Induced Internalization.Viruses2021https://conductscience.org/library/papers/34696383PubMed
34549974Asymmetric Structures and Conformational Plasticity of the Uncleaved Full-Length Human Immunodeficiency Virus Envelope Glycoprotein Trimer.J Virol2021https://conductscience.org/library/papers/34549974PubMed
33922579HIV-1 Entry and Membrane Fusion Inhibitors.Viruses2021https://conductscience.org/library/papers/33922579PubMed
33801906Immunogenicity of HIV-1-Based Virus-Like Particles with Increased Incorporation and Stability of Membrane-Bound Env.Vaccines (Basel)2021https://conductscience.org/library/papers/33801906PubMed
33310888Spike glycoprotein and host cell determinants of SARS-CoV-2 entry and cytopathic effects.J Virol2021https://conductscience.org/library/papers/33310888PubMed
33148792Dual Pathways of Human Immunodeficiency Virus Type 1 Envelope Glycoprotein Trafficking Modulate the Selective Exclusion of Uncleaved Oligomers from Virions.J Virol2021https://conductscience.org/library/papers/33148792PubMed
32817217Probing the Structure of the HIV-1 Envelope Trimer Using Aspartate Scanning Mutagenesis.J Virol2020https://conductscience.org/library/papers/32817217PubMed
32817216Antigenicity and Immunogenicity of HIV-1 Envelope Trimers Complexed to a Small-Molecule Viral Entry Inhibitor.J Virol2020https://conductscience.org/library/papers/32817216PubMed

See all 32 cited byDownload CSV of cited by

Genes4

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CD4920PubTator's text mininghttps://conductscience.org/library/genes/920NCBI Gene
ENPEP2028PubTator's text mininghttps://conductscience.org/library/genes/2028NCBI Gene
ERVK-20100616444PubTator's text mininghttps://conductscience.org/library/genes/100616444NCBI Gene
ITIH43700PubTator's text mininghttps://conductscience.org/library/genes/3700NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/29618643

GET https://conductscience.org/api/papers/v1/29618643/references?page=2